Nebulized Long-Acting Beta2-Agonists: More Than Just Bridging Gaps in the Management of Symptomatic COPD

机译：雾化的长效Beta2激动剂：在症状性COPD的管理中不仅弥合差距

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
作者
Daniel A. Gerardi; Nicholas J. Gross;
展开▼
作者单位

展开▼
年(卷),期 2017(4),1
年度 2017
页码 1–3
总页数 3
原文格式 PDF
正文语种
中图分类生理学;
关键词
copd chronic obstructive pulmonary disease long-acting beta2-agonists LABAs;

机译：copd;慢性阻塞性肺疾病;长效β2-激动剂;LABA;

相似文献

外文文献
中文文献
专利

1. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma–COPD overlap syndrome [J] . Suh-Young Lee, Hye Yun Park, Eun Kyung Kim, International Journal of Chronic Obstructive Pulmonary Disease . 2016,第1期

机译：哮喘-COPD重叠综合征的吸入类固醇和长效β2-激动剂的联合治疗
2. One-year mortality associated with COPD treatment: a comparison of tiotropium and long-acting beta2-agonists in three Italian regions: results from the OUTPUL study [J] . Kirchmayer Ursula, Cascini Silvia, Agabiti Nera, Pharmacoepidemiology and drug safety . 2016,第5期

机译：与COPD治疗相关的一年死亡率：噻托溴铵和长效β2-激动剂在意大利三个地区的比较：OUTPUL研究的结果
3. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS [J] . Latorre M., Novelli F., Vagaggini B., Pulmonary pharmacology & therapeutics . 2015,第Null期

机译：吸入性糖皮质激素（ICS）/长效β2-激动剂（LABA）组合在治疗慢性阻塞性肺疾病（COPD）中的功效和安全性差异：ICS的作用
4. Technical Validation of COPD Activity Support Monitor- Towards COPD Self-management [C] . Mark Paul Beattie, Huiru Zheng, Chris D. Nugent, International work conference on ambient assisted living . 2014

机译：COPD活动支持监视器的技术验证-面向COPD自我管理
5. Bridging Gaps in Information: Strategies for Improving Natural Resource Management in a Changing Climate [D] . Tracy, Erin . 2019

机译：弥补信息中的差距：改善气候变化中自然资源管理的策略
6. Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD [O] . Edward M Kerwin, Robert Tosiello, Barry Price, 2018

机译：背景长效β2受体激动剂治疗对新型COPD雾化的吡咯烷酸盐在中度至重度COPD患者中的疗效和安全性的影响
7. Nebulized Long-Acting Beta2-Agonists: More Than Just Bridging Gaps in the Management of Symptomatic COPD [O] . Daniel A. Geradi, Nicholas J. Gross 2017

机译：朦胧的长效β2-激动剂：不仅仅是弥漫在症状COPD管理中的差距
8. BREAKING STOVEPIPES: BRIDGING GAPS IN AIR FORCE INDUSTRIAL CONTROL SYSTEMS MANAGEMENT TO ENABLE MULTI-DOMAIN MISSION ASSURANCE. [R] . OBRUBA, P. J. 2016

机译：打破sTOVEpIpEs：在空军工业控制系统管理中弥补差距，实现多领域使命保障。

Nebulized Long-Acting Beta2-Agonists: More Than Just Bridging Gaps in the Management of Symptomatic COPD

著录项

相似文献

相关主题

期刊订阅